Strategic Approaches to Impurity Challenges in Combination Drug Products
In the dynamic universe where pharmaceuticals intersect, combination drug products have emerged as pioneers of innovation. This promising fusion, however, brings forth a symphony of challenges, notably in the realm of impurities. The Regulatory path for managing impurities in combination drug products is a nuanced journey, demanding a profound grasp of both pharmaceutical science and Regulatory intricacies.